Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SINOVAC BIOTECH LTD.

(SVA)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sinovac Biotech : Thailand delays plan to re-open cities to tourists until November

09/22/2021 | 04:32am EDT

BANGKOK, Sept 22 (Reuters) - Thailand has pushed back plans to re-open Bangkok and some other major cities to foreign arrivals until November, due to vaccination rates falling short of targets, a senior official said on Wednesday.

Officials earlier this month said they planned https://www.reuters.com/world/asia-pacific/thailand-hopes-welcome-tourists-bangkok-top-cities-next-month-2021-09-09 to welcome vaccinated tourists without quarantine to major cities like Bangkok, Hua Hin, Pattaya and Chiang Mai in October to revive the country’s crucial tourism sector.

"Cities we've targeted have not reached 70% vaccination rates and so we have to push out the date to November," Tourism Authority of Thailand (TAT) governor Yuthasak Supasorn told Reuters.

Despite being a production hub for the AstraZeneca vaccine, Thailand's vaccine rollout has struggled to keep pace, though Prime Minister Prayuth Chan-ocha pledged on Wednesday to speed up inoculations.

So far, 44% of residents in Bangkok have received two doses, government data shows. Overall, Thailand has vaccinated 22% of the estimated 72 million people living in the country.

Up to now, the tourism scheme https://www.reuters.com/article/uk-health-coronavirus-thailand-idUKKCN2E739E has only been launched on the islands of Samui and Phuket.

Thailand welcomed 40 million arrivals in 2019, who accounted for more than a fifth of gross domestic product, but this year is targeting one million visitors.

At least 98% of Thailand's more than 1.5 million coronavirus infections and 15,753 deaths happened since April this year due to an outbreak driven by the Delta variant. (Reporting by Panarat Thepgumpanat and Chayut Setboonsarng Editing by Ed Davies)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 1.09% 8962 Delayed Quote.21.01%
SINOVAC BIOTECH LTD. -0.31% 6.47 Delayed Quote.0.00%
All news about SINOVAC BIOTECH LTD.
10/18SINOVAC BIOTECH : Thailand to cease Sinovac vaccine use when stocks end this month
RE
10/06SINOVAC BIOTECH : Pfizer study to vaccinate whole Brazilian town against COVID-19
RE
10/01SINOVAC BIOTECH : Malaysia approves Sinovac's COVID-19 vaccine for ages 12 to 17
RE
09/29SINOVAC BIOTECH : Rebuffed by Bolsonaro, Brazil medical institute to sell vaccines abroad
RE
09/24CANSINO BIOLOGICS : CanSinoBIO's COVID vaccine, tested at lower dosage, safe for children ..
RE
09/22SINOVAC BIOTECH : Thailand delays plan to re-open cities to tourists until November
RE
09/15INDONESIA IN TALKS WITH WHO TO BECOM : minister
RE
09/09SINOVAC BIOTECH : Says its New Research Shows Third Dose if its COVID-19 Vaccine More Effe..
MT
09/09SINOVAC BIOTECH : New Research on SINOVAC's COVID-19 Vaccine Shows Third Dose More Effecti..
BU
09/08SINOVAC BIOTECH : Announces COVID-19 Vaccine Approved for Emergency Use in Chile for Child..
BU
More news
Financials (USD)
Sales 2020 511 M - -
Net income 2020 110 M - -
Net cash 2020 1 040 M - -
P/E ratio 2020 6,66x
Yield 2020 -
Capitalization 642 M 642 M -
EV / Sales 2019 1,86x
EV / Sales 2020 -0,78x
Nbr of Employees 1 959
Free-Float 33,5%
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | SVA | AGP8696W1045 | MarketScreener
Income Statement Evolution
Managers and Directors
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang CFO & Vice President-Business Development
Qiang Gao Chief Operating Officer & Vice President
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SINOVAC BIOTECH LTD.0.00%642
CSL LIMITED4.05%100 550
WUXI BIOLOGICS (CAYMAN) INC.10.02%61 723
SAMSUNG BIOLOGICS CO.,LTD.5.08%48 773
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.8.87%40 270